Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2025-08-05 Transaction in Own Shar…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 31 - 2025
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of share repurchases (transactions in own shares) by the company IPSEN, covering the period from July 28 to August 1, 2025. It includes tables listing individual transaction details such as date, time, volume, price, and market identifier. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-08-05 English
IPSEN - Buy-back programme - Art 5 of MAR - Week 31 - 2025
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of 'transactions in own shares' for the company IPSEN, covering a specific period (July 28th to August 1st 2025). It includes tables listing daily volumes, weighted average prices, and individual transaction details (broker, price, quantity, purpose of buyback). This aligns perfectly with the definition for 'Transaction in Own Shares' (POS).
2025-08-05 English
Ipsen S.A. publie son Rapport financier semestriel 2025 (semestre clos le 30 juin 2025)
Interim / Quarterly Report Classification · 1% confidence The document is titled 'RAPPORT FINANCIER SEMESTRIEL 2025' (Half-Year Financial Report 2025) and contains comprehensive consolidated financial statements (Income Statement, Balance Sheet, Cash Flow) for the first half of 2025. It includes detailed notes, management discussion, and auditor reports. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2025
2025-07-31 French
Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025)
Interim / Quarterly Report Classification · 1% confidence The document is titled '2025 HALF-YEAR FINANCIAL REPORT' and contains comprehensive consolidated financial statements (income statement, balance sheet, cash flow, and statement of changes in equity) for the first half of 2025. It includes detailed notes to the financial statements, an activity report, and a statutory auditor's report. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-07-31 English
Ipsen delivers strong results in the first half of 2025 and upgrades its full-year guidance
Earnings Release Classification · 1% confidence The document is a detailed financial results announcement for Ipsen for the first half of 2025 (H1 2025). It includes key financial highlights, management commentary, upgraded full-year guidance, pipeline updates, and detailed tables of sales by therapy area and geography. While it contains financial data, it is structured as an initial announcement of results (Earnings Release) rather than a full statutory interim report or a 10-K. It provides the 'key highlights' as defined in the Earnings Release (ER) category. H1 2025
2025-07-31 English
Ipsen publie de solides résultats au premier semestre 2025 et relève ses objectifs financiers annuels
Earnings Release Classification · 1% confidence The document is a detailed financial press release from Ipsen titled 'Ipsen publie de solides résultats au premier semestre 2025'. It contains comprehensive financial tables, management commentary, guidance updates, and operational highlights for the first half of 2025. While it is a press release, it serves as the primary disclosure of interim financial results, which falls under the 'Earnings Release' category. It is not a mere announcement of a report (RPA) because it contains the actual financial data and performance analysis. H1 2025
2025-07-31 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.